Webdisclosure.com

Search

SUNSHINE BIOPHARMA INC. (NASDAQ:SBFM ) EQS-News: NASDAQ: SBFM 👥 Enters Into A Collaboration Agreement For Its K1.1 Anticancer mRNA Project! 🔬

Directive transparence : information réglementée

23/11/2022 17:20

EQS-News: Sunshine Biopharma Inc.
NASDAQ: SBFM 👥 Enters Into A Collaboration Agreement For Its K1.1 Anticancer mRNA Project! 🔬

23.11.2022 / 17:20 CET/CEST
The issuer is solely responsible for the content of this announcement.


0.jpgContact Details

Christine Petraglia - TraDigital IR

+1 917-633-8980

investors@sunshinebiopharma.com

Company Website

https://sunshinebiopharma.com/


News Source: News Direct


23.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Sunshine Biopharma Inc.
United States
ISIN: US8677812054
EQS News ID: 1495061

 
End of News EQS News Service

1495061  23.11.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1495061&application_name=news&site_id=symex